جدول الترويج Turnstone Biologics Corp. Common Stock
الجدول الزمني المتقدم
رسم بياني بسيط
عن الشركة Turnstone Biologics Corp. Common Stock
Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, head and neck cancer and uveal melanoma, as well as an investigator sponsored trials to treat colorectal cancer, head and neck cancer, and cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. مزيد من التفاصيل| IPO date | 2023-07-21 |
|---|---|
| ISIN | US90042W1009 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://turnstonebio.com |
| Цена ао | 0.4 |
| تغير السعر يوميا: | 0% (0.377) |
|---|---|
| تغير السعر في الأسبوع: | +0.5333% (0.375) |
| تغير السعر شهريا: | +1.4% (0.3718) |
| تغير السعر خلال 3 أشهر: | -19.27% (0.467) |
| تغير السعر على مدى ستة أشهر: | -19.79% (0.47) |
| تغير السعر سنويا: | -86.54% (2.8) |
| تغير الأسعار منذ بداية العام: | -16.61% (0.4521) |
|
|
الاستهانة
|
كفاءة
|
|||||||||||||||||||||||||||||||||||||
توزيعات الأرباح
|
واجب
|
دافع النمو
|
|||||||||||||||||||||||||||||||||||||
| المؤسسات | مقدار | يشارك, % |
|---|---|---|
| Orbimed Advisors LLC. | 3099265 | 13.42 |
| FMR, LLC | 2546661 | 11.02 |
| Bank of America Corporation | 914058 | 3.96 |
| Point72 Asset Management, L.P. | 833333 | 3.61 |
| Eventide Asset Management LLC | 708317 | 3.07 |
| Citadel Advisors Llc | 688468 | 2.98 |
| PFM Health Sciences, LP | 633313 | 2.74 |
| 72 Investment Holdings, LLC | 549981 | 2.38 |
| Sectoral Asset Management, Inc. | 517648 | 2.24 |
| Blackrock Inc. | 301925 | 1.31 |
| مشرف | مسمى وظيفي | قسط | سنة الميلاد |
|---|---|---|---|
| Dr. Sammy J. Farah M.B.A., Ph.D. | President, CEO & Director | 678.51k | 1973 (52 سنة) |
| Dr. Venkat Ramanan Ph.D. | Chief Financial Officer | 346.13k | 1970 (55 سنين) |
| Dr. Michael F. Burgess M.D., MBChB, Ph.D. | Interim Chief Medical Officer & Executive Director | 212.69k | 1963 (62 سنة) |
| Ms. Saryah Azmat | Chief Business Officer | 479.73k | 1990 (35 سنين) |
| Dr. Vijay Chiruvolu M.B.A., Ph.D. | Interim Chief Technology Officer | N/A | 1962 (63 سنة) |
| Dr. David Stojdl Ph.D. | Senior Vice President of Research & Discovery | ||
| Dr. Ines Verdon M.D. | Senior Vice President of Clinical Development |
عنوان: United States, LA Jolla. CA, 9310 Athena Circle - مفتوحة في خرائط جوجل, فتح خرائط ياندكس
موقع إلكتروني: https://turnstonebio.com
موقع إلكتروني: https://turnstonebio.com
